Correlation Between Lumos Pharma and RenovoRx

Can any of the company-specific risk be diversified away by investing in both Lumos Pharma and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lumos Pharma and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lumos Pharma and RenovoRx, you can compare the effects of market volatilities on Lumos Pharma and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lumos Pharma with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lumos Pharma and RenovoRx.

Diversification Opportunities for Lumos Pharma and RenovoRx

0.0

Correlation Coefficient

Lumos Pharma  RenovoRx

Pay attention - limited upside

The 3 months correlation between Lumos and RenovoRx is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Lumos Pharma and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Lumos Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lumos Pharma are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Lumos Pharma i.e., Lumos Pharma and RenovoRx go up and down completely randomly.

Pair Corralation between Lumos Pharma and RenovoRx

If you would invest (100.00) in Lumos Pharma on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Lumos Pharma or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Lumos Pharma  vs.  RenovoRx

Lumos Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lumos Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy primary indicators, Lumos Pharma is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

RenovoRx

Risk-Adjusted Performance

Very Weak

Over the last 90 days RenovoRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Lumos Pharma and RenovoRx

The main advantage of trading using opposite Lumos Pharma and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lumos Pharma position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.

The idea behind Lumos Pharma and RenovoRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.